{"transactions":[{"id":1731157,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":107992,"kind":"person","name":"Hagopian Henry III","position":1,"cik":"0001821822","reported_name":"Hagopian Henry III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-22T21:21:13.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":820,"price":6.1,"value":5002.0,"ownership":{"direct":true},"balance_after":1820,"source":{"system":"sec-edgar","filing":"0001104659-23-120760","document":"tm2331305d8_4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923120760/tm2331305d8_4a.xml","form_type":"4/A","original_submission_date":"2023-11-21"}},{"id":1732545,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":107992,"kind":"person","name":"Hagopian Henry III","position":1,"cik":"0001821822","reported_name":"Hagopian Henry III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-21T19:29:31.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":824,"price":6.07,"value":5001.68,"ownership":{"direct":true},"balance_after":1824,"source":{"system":"sec-edgar","filing":"0001104659-23-120301","document":"tm2331305-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923120301/tm2331305-2_4seq1.xml","form_type":"4"}},{"id":1921741,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":107992,"kind":"person","name":"Hagopian Henry III","position":1,"cik":"0001821822","reported_name":"Hagopian Henry III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-12T01:08:59.000Z","date":"2023-04-07","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":12.61,"value":12610.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001104659-23-044206","document":"tm2312464-4_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923044206/tm2312464-4_4seq.xml","form_type":"4"}},{"id":2049601,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":107992,"kind":"person","name":"Hagopian Henry III","position":1,"cik":"0001821822","reported_name":"Hagopian Henry III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-20T22:42:04.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":7672,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight consecutive quarterly installments of 1,918 shares each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025."}],"balance_after":7672,"derivative":{"exercise_price":13.17,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":7672},"source":{"system":"sec-edgar","filing":"0001104659-23-005480","document":"tm234043-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923005480/tm234043-5_4seq1.xml","form_type":"4"}},{"id":2169942,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":107992,"kind":"person","name":"Hagopian Henry III","position":1,"cik":"0001821822","reported_name":"Hagopian Henry III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-09-01T00:14:11.000Z","date":"2022-08-29","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests one-third on August 29, 2023 and the remaining two-thirds will vest in eight consecutive quarterly installments beginning the fifteenth month after August 29, 2022, and will vest in full upon a Change of Control (as defined in the Company's 2019 Equity Incentive Plan), with vesting conditioned on continued employment on the applicable vesting dates."}],"balance_after":120000,"derivative":{"exercise_price":11.55,"expiration_date":"2032-08-29","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001104659-22-096653","document":"tm2224852-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922096653/tm2224852-2_4seq1.xml","form_type":"4"}},{"id":2905523,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":107992,"kind":"person","name":"Hagopian Henry III","position":1,"cik":"0001821822","reported_name":"Hagopian Henry III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-16T01:34:42.000Z","date":"2021-01-13","kind":"grant","acquired":true,"shares":64198,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in equal yearly installments over four years from the date of grant."}],"balance_after":64198,"derivative":{"exercise_price":7.34,"expiration_date":"2031-01-13","underlying":"Class A Common Stock","underlying_shares":64198},"source":{"system":"sec-edgar","filing":"0001661181-21-000003","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000166118121000003/edgar.xml","form_type":"4"}},{"id":2905522,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":107992,"kind":"person","name":"Hagopian Henry III","position":1,"cik":"0001821822","reported_name":"Hagopian Henry III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Class A Common Stock","published_at":"2021-01-16T01:34:42.000Z","date":"2021-01-13","kind":"grant","acquired":true,"shares":10700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Organogenesis Holdings Inc. (\"Organogenesis\") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years from the date of grant."}],"balance_after":12073,"source":{"system":"sec-edgar","filing":"0001661181-21-000003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000166118121000003/edgar.xml","form_type":"4"}},{"id":3047327,"issuer":{"id":6275,"kind":"organization","name":"Organogenesis Holdings Inc."},"owners":[{"id":107992,"kind":"person","name":"Hagopian Henry III","position":1,"cik":"0001821822","reported_name":"Hagopian Henry III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-25T20:34:18.000Z","date":"2020-08-21","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable in equal yearly installments over four years from the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":4.46,"expiration_date":"2030-08-21","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001661181-20-000029","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661181/000166118120000029/edgar.xml","form_type":"4"}}]}